COO Share Price Performance
US$71.02
-0.14 (-0.20%)
11.9% undervalued intrinsic discount
US$80.57
Fair Value
Price US$71.02
AnalystConsensusTarget US$80.57
AnalystLowTarget US$65.87
Fair ValueUS$80.57
Share Pricen/a
Narrative Update • Jun 23
The Cooper Companies, Inc. Stock Price
- 2 Narratives written by author
- 0 Comments on narratives written by author
- 30 Fair Values set on narratives written by author
COO Community Narratives
AN
Fair Value
·Fair Value US$80.57 11.9% undervalued intrinsic discount
COO: Share Buybacks And Merger Potential Will Drive Undervalued Stock Higher
0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AN
Fair Value
·Fair Value US$65.87 7.8% overvalued intrinsic discount
Premium Contact Lenses And Fertility Services Will Support Stable But Uneven Future Performance
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
COO: Share Buybacks And Merger Potential Will Drive Undervalued Stock Higher
Cooper Companies is coming out of a production bottleneck and is rolling out new premium contact lenses aimed at fast-growing needs like screen-heavy lifestyles and myopia control. The bigger question is whether these launches and efficiency gains can outpace price pressure and softer demand in parts of its surgical and fertility business.Read more
AN
US$80.57
11.9% undervalued intrinsic discount
Fair Value
Revenue
5.12% p.a.
Profit Margin
16.63%
Future PE
22.76x
Price in 2029
US$101.02
Premium Contact Lenses And Fertility Services Will Support Stable But Uneven Future Performance
Cooper Companies looks steady on the surface, but its growth could get choppy as it shifts customers toward newer contact lenses and tries to reignite demand in its fertility business. See what could keep profits from improving much, even as popular eye products and cost cuts give it a chance to surprise on the upside.Read more
AN
US$65.87
7.8% overvalued intrinsic discount
Fair Value
Revenue
4.45% p.a.
Profit Margin
17.09%
Future PE
18.73x
Price in 2029
US$82.97
Trending Discussion
Recently Updated Narratives
AN
COO: Future Upside Will Depend On EPS Strength And Completed Buybacks
Fair Value: US$80.57 11.9% undervalued intrinsic discount
15 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Premium Contact Lenses And Fertility Services Will Support Stable But Uneven Future Performance
Fair Value: US$65.87 7.8% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
The Cooper Companies, Inc. Key Details
About COO
- Founded
- 1958
- Employees
- 15000
- CEO
- WebsiteView website
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Recent COO News & Updates
Analysis Article • Jun 19
